FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy
Related Topics >> China

ProGenTech gains $21M in third venture round

ProGenTech, with operations in California and China, has pocketed $21 million in its third round of venture financing. The biotech company markets products for research and medical diagnostics and is developing a contamination free, cassette based automated nucleic acid purification system. Bay City Capital and DT Capital led the round. ProGenTech was founded by two engineers: Steve Yu and Jesus Ching. Yu will remain a director of the company and become its president and COO. Ching will become the chief scientific officer of ProGenTech.

- check out the press release

More stories about China  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 10 + 5?
To combat spam, please solve the math question above.